UCB (UCB)

Index:

BEL 20

  168.90
   
  • Change Today:
     5.30
  • 52 Week High:  196.80
  • 52 Week Low:  129.35
  • Currency: Euro
  • Shares Issued: 190.00m
  • Volume: 177,762
  • Market Cap:  32,091m
  • Beta: 1.56

Latest ShareCast News

Belgium's UCB to buy US-based Ra Pharmaceuticals for $2.1bn

By Michele Maatouk

Date: Thursday 10 Oct 2019

(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

UCB Market Data

Currency Euro
Share Price   168.90
Change Today   5.30
% Change 3.24 %
52 Week High  196.80
52 Week Low  129.35
Volume 177,762
Shares Issued 190.00m
Market Cap  32,091m
Beta 1.56

What The Brokers Say

Strong Buy 6
Buy 9
Neutral 5
Sell 0
Strong Sell 0
Total 20
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 04-Jul-2025

Time Volume / Share Price
17:35 109 @  168.90
17:35 190 @  168.90
17:35 149 @  168.90
17:35 5 @  168.90
17:35 26 @  168.90

Top of Page